CATALOGO DEI PRODOTTI DELLA RICERCA

VOLTATTORNI, Carla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.606
EU - Europa 5.757
AS - Asia 4.886
SA - Sud America 528
AF - Africa 83
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.875
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.469
RU - Federazione Russa 2.004
SG - Singapore 1.939
CN - Cina 1.725
GB - Regno Unito 1.626
BR - Brasile 424
HK - Hong Kong 399
FR - Francia 336
SE - Svezia 335
VN - Vietnam 334
IT - Italia 333
FI - Finlandia 308
DE - Germania 307
IE - Irlanda 226
KR - Corea 148
UA - Ucraina 132
CA - Canada 85
IN - India 64
BD - Bangladesh 58
JP - Giappone 58
AR - Argentina 39
MX - Messico 33
TR - Turchia 33
BE - Belgio 25
NL - Olanda 24
ID - Indonesia 23
ZA - Sudafrica 22
IQ - Iraq 21
PL - Polonia 19
EC - Ecuador 18
NG - Nigeria 18
CL - Cile 14
SA - Arabia Saudita 14
ES - Italia 13
UZ - Uzbekistan 12
PK - Pakistan 11
LT - Lituania 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
AU - Australia 9
CO - Colombia 8
UY - Uruguay 8
BG - Bulgaria 7
EG - Egitto 7
CH - Svizzera 6
GR - Grecia 6
LV - Lettonia 6
PH - Filippine 6
PY - Paraguay 6
IL - Israele 5
JM - Giamaica 5
RO - Romania 5
TN - Tunisia 5
VE - Venezuela 5
KE - Kenya 4
AZ - Azerbaigian 3
CR - Costa Rica 3
EU - Europa 3
GA - Gabon 3
JO - Giordania 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
TG - Togo 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
LU - Lussemburgo 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GH - Ghana 1
GN - Guinea 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 18.862
Salva come PNG Salva come JPEG
Città #
Southend 1.443
Singapore 1.062
Jacksonville 1.060
Ashburn 808
San Jose 780
Moscow 630
Chandler 621
Woodbridge 564
Dallas 551
Hong Kong 393
Ann Arbor 370
Houston 296
Beijing 224
Dublin 224
Verona 213
The Dalles 188
Jinan 150
Nanjing 138
Wilmington 131
Lawrence 128
Princeton 128
Shenyang 126
Ho Chi Minh City 119
Los Angeles 109
New York 95
Hanoi 91
Tianjin 77
Sindelfingen 73
Hebei 72
Buffalo 70
Changsha 67
Helsinki 63
Boardman 62
Council Bluffs 59
Ningbo 53
Tokyo 52
Nanchang 51
Columbus 50
Haikou 47
Santa Clara 46
Milan 45
São Paulo 45
Zhengzhou 44
Hangzhou 41
Munich 40
Taiyuan 36
Guangzhou 33
Jiaxing 32
Philadelphia 32
Taizhou 32
San Francisco 31
Lanzhou 29
Toronto 28
Montreal 27
Redondo Beach 27
Orem 26
Brooklyn 25
Fuzhou 25
Lancaster 25
Chicago 23
Seattle 22
Brussels 21
Chennai 21
Norwalk 21
London 20
Belo Horizonte 19
Boston 19
Frankfurt am Main 19
Johannesburg 18
Seoul 18
Warsaw 18
Falls Church 16
Redmond 16
Abuja 15
Denver 15
Phoenix 15
Haiphong 14
Stockholm 14
Auburn Hills 12
Detroit 12
Jakarta 12
Mexico City 12
Rio de Janeiro 11
Tashkent 11
Amsterdam 10
Da Nang 10
Manchester 9
Atlanta 8
Clearwater 8
Fairfield 8
Kent 8
Quito 8
Riva 8
Shanghai 8
Berlin 7
Can Tho 7
Dearborn 7
Dhaka 7
Elora 7
Falkenstein 7
Totale 12.648
Salva come PNG Salva come JPEG
Nome #
Dimerization and Folding Processes of Treponema denticola Cystalysin: The Role of Pyridoxal 5'-Phosphate 283
Holo-and apocystalysin from Treponema denticola: two different conformations 270
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 262
Pyridoxal 5’-Phosphate Enzymes as Targets for Therapeutic Agents 253
A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications 233
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications 227
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 225
Affinity labelling of pig kidney Dopa decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. Modification of an active site cysteine 222
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 204
Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli 202
Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidative deaminase activities toward serotonin (5-hydroxytryptamine) 201
Folding defects leading to primary hyperoxaluria 201
An engineered folded PLP-bound monomer of Treponema denticola cystalysin reveals the effect of the dimeric structure on the catalytic properties of the enzyme 199
A quinonoid is an intermediate of oxidative deamination reaction catalyzed by Dopa decarboxylase 196
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 194
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 192
An essential arginine residue at the binding site of pig kidney 3,4-dihydroxyphenylalanine decarboxylase 190
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 190
Chemical modification of pig kidney 3,4-dihydroxyphenylalanine decarboxylase with diethyl pyrocarbonate. Evidence for an essential histidyl residue 189
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants. 189
Cysteine 180 Is a Redox Sensor Modulating the Activity of Human Pyridoxal 5'-Phosphate Histidine Decarboxylase 182
Cystalysin: an example of the catalytic versatility of pyridoxal 5'-phosphate dependent enzymes 181
New variants of AADC deficiency expand the knowledge of enzymatic phenotypes 181
The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase 178
Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli 176
Aromatic amino acid methyl ester analogs form quinonoidal species with Dopa decarboxylase 174
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: Glyoxylate aminotransferase and the F152I mutation 173
Behavior of fluorinated analogs of L-(3,4-dihydroxyphenyl)alanine and L-threo-(3,4-dihydroxyphenyl)serine as substrates for Dopa decarboxylase 172
Phosphorylation of pyridoxal 5'-phosphate enzymes: an intriguing and neglected topic 172
An affinity labeling reagent for pyridoxal phosphate dependent enzymes 170
Alpha5 pyridoxalacetic acid and alpha5 pyridoxyl-L-phenylalanine acetic acid: their action on some B6-dependent enzymes 167
Mutation of residues in the coenzyme binding pocket of Dopa decarboxylase: effects on catalytic properties 162
Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook 162
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: glyoxylate aminotransferase and the f152i mutation 161
New insights emerging from recent investigations on human group II pyridoxal 5'-phosphate Decarboxylases 159
[Preparation and properties of the beta-Hp-Hb complex] 158
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 157
[Binding of pyridoxyl derivatives to apoaspartate transaminase from swine hearts] 156
[Action of pyridoxyl-glutamic acid on transaminases] 155
Deficit of human ornithine aminotransferase in gyrate atrophy: Molecular, cellular, and clinical aspects 155
Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors 155
Dopa decarboxylase: the pig kidney enzyme primary structure and relationship to other amino acid decarboxylases 154
Site-directed mutagenesis provides insight into racemization of alanine catlayzed by "Treponema denticola" cystalysin 153
[Binding of phosphopyridoxyl derivatives to apoaspartate aminotransferase from wheat germ] 152
Pig kidney dopa decarboxylase: inactivation by iodoacetamide and sequence of the carboxyamidomethylcysteine-containing peptide 151
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 151
[Inhibition of APO-DOPA-decarboxylase by phosphopyridoxyl-amino acids] 150
[Preliminary studies of apo-tyrosine decarboxylase inhibitors] 150
Cloning and expression of pig kidney dopa decarboxylase: comparison of the naturally occurring and recombinant enzymes 150
Crystallization and preliminary X-ray analysis of pig kidney DOPA decarboxylase 149
An abnormal reaction occurring in the presence of L-aromatic aminoacid decarboxylase 149
R180T variant of δ-ornithine aminotransferase associated with gyrate atrophy: biochemical, computational, X-RAY and NMR studies provide insight into its catalytic features 149
Structural and functional aspects of the active site in aspartate aminotransferase 148
Stereospecificity of sodium borohydride reduction of pig kidney dopa decarboxylase 148
Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina 148
[Separation of pyridoxal phosphate dependent enzymes by means of carboxymethylcellulose hydrazide] 147
Thermodynamic parameters for substrate-coenzyme protein complex formation in b6-dependent enzymes 147
A new assay for DOPA decarboxylase activity 146
[Interaction of dopa decarboxylase from swine kidney with thiosemicarbazone] 146
Dopa decarboxylase 145
Biochemical and bioinformatic studies of mutations of residues at the monomer-monomer interface of human ornithine aminotransferase leading to gyrate atrophy of choroid and retina 143
A novel compound heterozygous genotype associated with aromatic amino acid decarboxylase deficiency: Clinical aspects and biochemical studies 143
Spectroscopic and kinetic analyses reveal the pyridoxal 5'-phosphate binding mode and the catalytic features of Treponema denticola cystalysin 143
Tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex: a novel catecholaminergic group? 140
[Effect of pH on the interaction of 3'-nucleotidase from wheat germ with 5'-phosphate nucleotides] 140
[Study of the inhibition of the 3'-nucleotidase of the wheat germ by 5'-nucleotides] 139
[Effect of Mg++ ion on 5-nucleotidase activity] 138
DISSOCIATION, UNFOLDING AND REFOLDING TRIALS OF PIG KIDNEY 3,4-DIHYDROXYPHENYLALANINE (DOPA) DECARBOXYLASE 137
Heterozygosis in aromatic amino acid decarboxylase deficiency: Evidence for a positive interallelic complementation between R347Q and R358H mutations 137
Mutation of cysteine 111 in dopa decarboxylase leads to active site perturbation 136
Insights into the mechanism of oxidative deamination catalyzed by Dopa decarboxylase 135
Lysine 238 is an essential residue for alfa, beta- elimination catalyzed by "Treponema denticola" cystalysin 134
[Preliminary studies on inhibitors of apo-tyrosine transaminase] 132
Dopaminergic and noradrenergic sympathetic nerves of the dog have different DOPA decarboxylase activities 131
Pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. Primary structure and relationships to other amino acid decarboxylases 131
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. 131
Aromatic L-amino acid decarboxylase. Immunoreactive cells in the tuberal of the carboxyamidomethylcysteine 130
Interaction of aromatic amino acids in D and L forms with 3,4-dihydroxyphenylalanine decarboxylase from pig kidney 130
Reactions of DOPA (3,4-dihydroxyphenylalanine) decarboxylase with DOPA 130
Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies 130
Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency. 128
Time-resolved extrinsic fluorescence of aromatic-L-amino-acid decarboxylase 127
Purification and characterization of rat-liver 3,4-dihydroxyphenylalanine decarboxylase 127
Mechanism-based inactivation of dopa decarboxylase by serotonin 127
The binding of nucleotides to 3'-nucleotidase from wheat germ 126
The binding of coenzymes and analogues of the substrate-coenzyme complex to tyrosine aminotransferase 125
The binding of the coenzyme pyridoxal 5'-phosphate and analogues of the substrate-coenzyme complex to tyrosine decarboxylase 123
Dopa decarboxylase 123
Reaction specificity of native and nicked 3,4-dihydroxyphenylalanine decarboxylase 123
The steady state kinetics of tyrosine decarboxylase from Streptococcus faecalis 122
The use of 4'-N-(2,4-dinitro-5-fluorophenyl)-pyridoxamine 5'-phosphate 121
Treponema denticola cystalysin catalyzes beta-desulfination of L-cysteine sulfinic acid and beta-decarboxylation of L-aspartate and oxalacetate 121
Characterization of DOPA decarboxylase mRNA in rat pheochromocytoma 119
Pig kidney dopa decarboxylase. Structure and function 119
Spectral properties of the coenzyme bound to dopa decarboxylase from pig kidney 118
Treponema denticola cystalysin exhibits a significant alanine racemase activity accompanied by transamination: mechanistic implications 118
Interaction of L-alpha-methyl-alpha-hydrazino-3,4 dihydroxyphenylpropionic acid with dopa-decarboxylase from pig kidney 117
Reactions of human liver peroxisomal alanine:glyoxylate aminotransferase with beta-chloro-L-alanine and L-cysteine: spectroscopic and kinetic analysis 116
Targeting Cystalysin, a Virulence Factor ofTreponema denticola-Supported Periodontitis 115
Reaction of Dopa decarboxylase with alfa-methylDopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active-site directed affinity label 113
Totale 15.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.204
article - articoli 57.025
book - libri 0
conference - conferenze 467
curatela - curatele 0
other - altro 437
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.275
Totale 120.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 0 0 0 0 0 37
2021/20221.223 116 407 129 45 22 20 12 56 39 19 72 286
2022/20231.973 167 154 185 345 212 432 32 122 226 13 59 26
2023/2024776 42 80 62 188 58 76 25 41 3 22 126 53
2024/20252.545 199 152 38 442 124 43 129 121 398 173 234 492
2025/20267.045 569 322 602 965 1.644 456 809 384 621 428 124 121
Totale 18.990